[artículo] 
inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 10 (Octubre) . - pp. 1683-1689

Título :	Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia : A double-blind, randomized, placebo-controlled trial
Tipo de documento:	texto impreso
Autores:	Javier Labad Arias, Autor ; Lourdes Martorell, Autor ; Elena Huerta Ramos, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 1683-1689
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	Raloxifeno, Síntomas negativos, Esquizofrenia, Genética, Farmacogenética, Post menopausia
Resumen:	Several double-blind clinical trials have reported improvement in positive, negative and cognitive symptoms of schizophrenia with raloxifene, a selective receptor estrogen modulator. However, there are some inconsistencies in replicating findings between studies of different countries.
Link:	./index.php?lvl=notice_display&id=26494

[artículo] Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia : A double-blind, randomized, placebo-controlled trial [texto impreso] / Javier Labad Arias, Autor ; Lourdes Martorell, Autor ; Elena Huerta Ramos, Autor . - 2021 . - pp. 1683-1689.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 10 (Octubre) . - pp. 1683-1689

Etiquetas:	Raloxifeno, Síntomas negativos, Esquizofrenia, Genética, Farmacogenética, Post menopausia
Resumen:	Several double-blind clinical trials have reported improvement in positive, negative and cognitive symptoms of schizophrenia with raloxifene, a selective receptor estrogen modulator. However, there are some inconsistencies in replicating findings between studies of different countries.
Link:	./index.php?lvl=notice_display&id=26494